Browsing by Author "FERREIRA, Júlia Eliza"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Piodermatite Profunda: relato de caso(Fundação de Ensino Octávio Bastos, 2022-09-09) MICHELETTI, Carolina Dantas; BENTO, Maria Gabriela; SANTOS, Pedro Henrique Avelino dos; FERREIRA, Júlia Eliza; SOUZA, Mariely Thaís deDeep pyoderma is a dermatological condition increasingly present in the veterinary clinical routine, caused by a pyogenic infection of bacterial origin. This paper describes a case of deep pyoderma in an eight-year-old, mixed-breed bitch, who had skin complaints since she was four years old, with a history of unresponsive treatments. The animal had alopecic areas, hyperpigmentation, papules, pustules, hyperkeratosis and generalized desquamation. The diagnosis was confirmed through histopathological examination, which indicated the presence of cellulitis, furunculosis and folliculitis, so the treatment consisted of antibiotic therapy, whose clinical improvement was significant.Item Síndrome da disfunção cognitiva em cães(Centro Universitário da Fundação de Ensino Octávio Bastos, 2019-09-18) PIROLA, Júlia Cecília; FERREIRA, Júlia Eliza; SOUZA, Mariely Thaís deCognitive dysfunction syndrome in dogs (CCDS) is characterized by behavioral changes in geriatric dogs, due to neurodegeneration. The most observed clinical signs are changes in the sleep-wake cycle, gradual cognitive loss with sensory deficits, changes in learning ability, memory, spatial notions, social interactions and decrease in normal daily activities. The prevalence of this disease can happen from the age of six, when the animal begins to show discrete signs of cognitive dysfunction, however, the most evident changes start from 11 years of age. In the diagnosis, in addition to observing behavioral changes suggestive of CCDS, several complementary exams are indicated, such as blood count, serum biochemistry and hormonal tests, ruling out the influence of diseases that can lead to neurological changes such as diabetes, hypothyroidism, renal failure, among others; the definitive diagnosis is obtained by histopathological examination of the nervous tissue, obtained by biopsy in vivo or, in general, in the post-mortem period. The treatment consists of preventing the advance of the neurodegenerative process and restoring the concentrations of neurotransmitters.